Akero Therapeutics
AKRO
AKRO
156 hedge funds and large institutions have $1.84B invested in Akero Therapeutics in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
30% less capital invested
Capital invested by funds: $2.65B → $1.84B (-$806M)
Holders
156
Holding in Top 10
7
Calls
$25.3M
Puts
$16.9M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$40.7M | |
| 3 | +$22.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$18M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.5M |
Top Sellers
| 1 | -$52.7M | |
| 2 | -$52.6M | |
| 3 | -$33.1M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$22.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$16.1M |